Author:
Goonewardene Sanchia S.,Persad Raj,Motiwala Hanif,Albala David
Publisher
Springer International Publishing
Reference9 articles.
1. Harano M, Eto M, Nakamura M, et al. A pilot study of the assessment of the quality of life, functional results, and complications in patients with an ileal neobladder for invasive bladder cancer. Int J Urol. 2007;14(2):112–7.
2. Mohamed NE, Pisipati S, Lee CT, Goltz HH, Latini DM, Gilbert FS, Wittmann D, Knauer CJ, Mehrazin R, Sfakianos JP, McWilliams GW, Quale DZ, Hall SJ. Unmet informational and supportive care needs of patients following cystectomy for bladder cancer based on age, sex, and treatment choices. Urol Oncol. 2016;34(12):531.e7–14.
3. Oddens JR, Sylvester RJ, Brausi MA, Kirkels WJ, van de Beek C, van Andel G, de Reijke TM, Prescott S, Witjes JA, Oosterlinck W. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911. Eur Urol. 2014;66(4):694–701.
4. Prout GR Jr, Wesley MN, Yancik R, Ries LAG, Havlik RJ, Edwards BK. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: as population-based study. Cancer. 2005;104(8):1638–47.
5. Saika T, Arata R, Tsushima T, et al. Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with an ileal conduit, ureterocutaneostomy, or orthotopic urinary reservoir: a comparative questionnaire survey. Acta Med Okayama. 2007;61(4):199–203.